Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6481430 | 1.00 | ALDH1A1 (0.37) | ALDH1A1APLNR | |
| SCHEMBL6498785 | 1.00 | ALDH1A1 (0.37) | ALDH1A1APLNR | |
| SCHEMBL6481437 | 1.00 | ALDH1A1 (0.37) | ALDH1A1APLNR | |
| SCHEMBL6484661 | 1.00 | ALDH1A1 (0.37) | ALDH1A1APLNR | |
| SCHEMBL30190121 | 0.81 | APLNR (0.31) | APLNR | |
| SCHEMBL13135988 | 0.78 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL2888135 | 0.78 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL2888132 | 0.78 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL14460704 | 0.77 | ALDH1A1 (0.58) | ALDH1A1 | |
| SCHEMBL4596643 | 0.77 | ALDH1A1 (0.58) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6969712-B2 | Benzimidazole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-11-29 | — | — | US | disclosed |
| US-20040044056-A1 | Benzimidazole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2004-03-04 | — | — | US | disclosed |
| EP-1342717-A1 | BENZIMIDAZOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2003-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044056-A1 | Benzimidazole derivatives | GPR119, OPRL1, INSR | ALDH1A1 1851/4885APLNR 231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.